Ambalal Sarabhai Enterprises Ltd

At Rs 39.22, sellers were still queuing — but there were no buyers willing to take the other side. Ambalal Sarabhai Enterprises Ltd locked at its lower circuit of 5% on 18 Sep 2026, with unfilled sell orders and a frozen price that capped losses at 3.83% for the day.

Ambalal Sarabhai Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 16 September 2026, providing investors with an up-to-date view of the company's performance and outlook.

Ambalal Sarabhai Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date perspective on its performance and outlook.

Ambalal Sarabhai Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 August 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

At Rs 45.36, sellers were still queuing — but there were no buyers willing to take the other side. Ambalal Sarabhai Enterprises Ltd locked at its lower circuit of 5.0% on 21 Aug 2026, with unfilled sell orders and a frozen price.

Surging from a 52-week low of Rs 23.12 to a fresh high of Rs 49.98 on 20 Aug 2026, Ambalal Sarabhai Enterprises has more than doubled in value over the past year, outpacing the Sensex which declined by 5.36% in the same period. This rally is underpinned by a confluence of bullish technical indicators and sustained price momentum.

Ambalal Sarabhai Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 August 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 14 August 2026, providing investors with the latest insights into the stock’s performance and outlook.

With a sustained rally that has propelled Ambalal Sarabhai Enterprises Ltd to a fresh 52-week high of Rs 49.6 on 10 Aug 2026, the stock’s momentum is underpinned by a confluence of bullish technical indicators and robust price action.

Ambalal Sarabhai Enterprises Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive, signalling enhanced price appeal for investors. This change accompanies robust stock performance that has significantly outpaced the Sensex over multiple time horizons, underscoring the company’s growing market stature within the Pharmaceuticals & Biotechnology sector.

With a decisive surge to Rs 46.7 on 7 Aug 2026, Ambalal Sarabhai Enterprises Ltd has reached a fresh 52-week high, marking a remarkable 53.16% gain over the past year. This rally is underpinned by a confluence of bullish technical indicators and sustained price momentum, even as the broader Sensex trades lower.

Ambalal Sarabhai Enterprises Ltd, a player in the Pharmaceuticals & Biotechnology sector, reached a significant milestone on 5 August 2026 by touching a new 52-week high of Rs.43.4. This achievement marks a continuation of the stock’s strong upward momentum over the past year, reflecting robust financial performance and positive market dynamics.

With a decisive break above Rs 39 on 4 Aug 2026, Ambalal Sarabhai Enterprises Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over the past week.

Ambalal Sarabhai Enterprises Ltd has seen its investment rating upgraded from Hold to Buy, driven by a marked improvement in technical indicators, robust quarterly financial results, attractive valuation metrics, and a positive financial trend. The company’s mojo score has risen to 74.0, reflecting renewed investor confidence amid a micro-cap pharmaceutical sector backdrop.

Ambalal Sarabhai Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 26 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Ambalal Sarabhai Enterprises Ltd is rated Hold by MarketsMOJO. This rating was last updated on 08 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 15 July 2026, providing investors with the most recent insights into the company's performance and outlook.

Ambalal Sarabhai Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 July 2026, providing investors with the latest insights into its performance and outlook.